Cardiac Output and Fatigue in Friedreich's Ataxia
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a clinical trial examining to impact of aerobic training plus omaveloxolone in FRDA. Thirty individuals with FRDA will be recruited; 20 individuals will be on omaveloxolone treatment whereas the other ten individuals will not. Individuals will undergo baseline assessment including cardiopulmonary exercise testing (CPET), mFARS, gait speed, Timed Up and Go (TUG), Fatigue Severity Scale (FSS), Fatigue Impact Scale (FIS), and 6-minute Walk Test (6MWT). Individuals will then perform 3-months of home aerobic training. Repeat assessments will be conducted at 3- and 6-months.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Genetically confirmed FRDA
• Ability to safely ride a stationary bicycle (mFARS sitting posture sub-score \<2)
Locations
United States
New York
Columbia University Irving Medical Center
RECRUITING
New York
Contact Information
Primary
Scott Barbuto, MD PhD
sb3779@cumc.columbia.edu
12123054818
Time Frame
Start Date: 2026-07-15
Estimated Completion Date: 2028-04-01
Participants
Target number of participants: 30
Treatments
Experimental: Home Aerobic Training on Omaveloxolone
Participants who are currently taking Skyclarys (omaveloxolone) will be given a recumbent exercise bike (Marcy ME-709 Adjustable Recumbent Exercise Bike, Pomona, CA) for home use. They will be instructed to exercise five times a week. The regimen will include 5-minute warm up, 30 minutes of exercise at target heart rate, and 5 minutes of cool down.
Active_comparator: Home Aerobic Training off Omaveloxolone
Participants who are not taking Skyclarys (omaveloxolone) will be given a recumbent exercise bike (Marcy ME-709 Adjustable Recumbent Exercise Bike, Pomona, CA) for home use. They will be instructed to exercise five times a week. The regimen will include 5-minute warm up, 30 minutes of exercise at target heart rate, and 5 minutes of cool down.
Related Therapeutic Areas
Sponsors
Leads: Scott Barbuto
Collaborators: Biogen